Abstract
ABSTRACTBackground: The paper reports on two cases of fibrodysplasia ossificans progressiva, a genetically determined condition with no pathogenetic treatment. The pathophysiology of the disease is known partially only. Clinically, it is characterized by flare-ups accompanied by severe pain and ectopic ossifications.Findings: The patients’ general condition improved when they were continuously treated with ascorbic acid and periodically received disodium clodronate. The latter reduced the duration and intensity of flare-ups. Early administration of intravenous disodium clodronate at pain onset can prevent flare-ups.Conclusion: Ascorbic acid diminishes pain and makes flare-ups less frequent. The study provides evidence of a possible synergism of ascorbic acid and disodium clodronate during the long-term treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
